Nimbolide inhibits tumor growth by restoring hepatic tight junction protein expression and reduced inflammation in an experimental hepatocarcinogenesis.

World J Gastroenterol · 2020 · PMC7723674 · PMID 33362373

Europe PMC DOI

hedged sentence

0.6781

closest p · 13.6× alpha

0.6781

boldest claim

The sentences

showed a trendP = 0.6781not close (p > 0.1)

Nimbolide or doxorubicin treatment to HCC mice showed a trend in increased body weight from 28 th to 32 nd week ( P = 0.6781) (Figure 1B ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.